Mechanistically, STAT1KD predisposed human HNSCC and melanoma cells to RT-driven suppression of glycolysis and lactate dehydrogenase A (a key enzyme in glycolysis), suggesting that STAT1 can protect tumor cells from RT-induced deprivation of energy and cell killing [67]. Here, STAT1 is linked to melanoma.